Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB

William Rengifo-Cam, Shahid Umar, Shubhashish Sarkar, Pomila Singh

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Progastrin (PG) exerts proliferative and antiapoptotic effects on intestinal epithelial and colon cancer cells via Annexin II (ANX-II). In here, we show that ANX-II similarly mediates proliferative and antiapoptotic effects of PG on a pancreatic cancer cell line, AR42J. The role of several signaling molecules was examined in delineating the biological activity of PG. PG (0.1-1.0 nmol/L) caused a significant increase (2- to 5-fold) in the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt (Thr308), p38 mitogen-activated protein kinase (MAPK; Thr180/Tyr182), extracellular signal-regulated kinases (ERK; Thr202/Tyr 204), IκB kinase α/β (IKKα/β; Ser 176/180), IκBα (Ser32), and p65 nuclear factor-κB (NF-κB; Ser536). Inhibition of p44/42 ERKs (PD98059), p38 MAPK (SB203580), Akt, and PI3K (LY294002), individually or combined, partially reversed antiapoptotic effects of PG. The kinetics of phosphorylation of IKKα/β in response to PG matched the kinetics of phosphorylation and degradation of IκBβ and correlated with phosphorylation, nuclear translocation, and activation of p65 NF-κB. NF-κB essential modulator-binding domain peptide (an inhibitor of IKKα/β) effectively blocked the activity of p65 NF-κB in response to PG. Activation of p65 NF-κB, in response to PG, was 70% to 80% dependent on phosphorylation of MAPK/ERK and PI3K/Akt molecules. Down-regulation of p65 NF-κB by specific small interfering RNA resulted in the loss of antiapoptotic effects of PG on AR42J cells. These studies show for the first time that the canonical pathway of activation of p65 NF-κB mediates antiapoptotic effects of PG. Therefore, targeting PG and/or p65 NF-κB may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth.

Original languageEnglish (US)
Pages (from-to)7266-7274
Number of pages9
JournalCancer Research
Volume67
Issue number15
DOIs
StatePublished - Aug 1 2007

Fingerprint

Pancreatic Neoplasms
Phosphatidylinositol 3-Kinase
Phosphorylation
Annexin A2
p38 Mitogen-Activated Protein Kinases
big gastrin
Intestinal Neoplasms
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
Extracellular Signal-Regulated MAP Kinases
Colonic Neoplasms
Small Interfering RNA
Phosphotransferases
Down-Regulation
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB. / Rengifo-Cam, William; Umar, Shahid; Sarkar, Shubhashish; Singh, Pomila.

In: Cancer Research, Vol. 67, No. 15, 01.08.2007, p. 7266-7274.

Research output: Contribution to journalArticle

Rengifo-Cam, William ; Umar, Shahid ; Sarkar, Shubhashish ; Singh, Pomila. / Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB. In: Cancer Research. 2007 ; Vol. 67, No. 15. pp. 7266-7274.
@article{154d1bcecfc94807adb523827dc00c31,
title = "Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB",
abstract = "Progastrin (PG) exerts proliferative and antiapoptotic effects on intestinal epithelial and colon cancer cells via Annexin II (ANX-II). In here, we show that ANX-II similarly mediates proliferative and antiapoptotic effects of PG on a pancreatic cancer cell line, AR42J. The role of several signaling molecules was examined in delineating the biological activity of PG. PG (0.1-1.0 nmol/L) caused a significant increase (2- to 5-fold) in the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt (Thr308), p38 mitogen-activated protein kinase (MAPK; Thr180/Tyr182), extracellular signal-regulated kinases (ERK; Thr202/Tyr 204), IκB kinase α/β (IKKα/β; Ser 176/180), IκBα (Ser32), and p65 nuclear factor-κB (NF-κB; Ser536). Inhibition of p44/42 ERKs (PD98059), p38 MAPK (SB203580), Akt, and PI3K (LY294002), individually or combined, partially reversed antiapoptotic effects of PG. The kinetics of phosphorylation of IKKα/β in response to PG matched the kinetics of phosphorylation and degradation of IκBβ and correlated with phosphorylation, nuclear translocation, and activation of p65 NF-κB. NF-κB essential modulator-binding domain peptide (an inhibitor of IKKα/β) effectively blocked the activity of p65 NF-κB in response to PG. Activation of p65 NF-κB, in response to PG, was 70{\%} to 80{\%} dependent on phosphorylation of MAPK/ERK and PI3K/Akt molecules. Down-regulation of p65 NF-κB by specific small interfering RNA resulted in the loss of antiapoptotic effects of PG on AR42J cells. These studies show for the first time that the canonical pathway of activation of p65 NF-κB mediates antiapoptotic effects of PG. Therefore, targeting PG and/or p65 NF-κB may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth.",
author = "William Rengifo-Cam and Shahid Umar and Shubhashish Sarkar and Pomila Singh",
year = "2007",
month = "8",
day = "1",
doi = "10.1158/0008-5472.CAN-07-1206",
language = "English (US)",
volume = "67",
pages = "7266--7274",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "15",

}

TY - JOUR

T1 - Antiapoptotic effects of progastrin on pancreatic cancer cells are mediated by sustained activation of nuclear factor-κB

AU - Rengifo-Cam, William

AU - Umar, Shahid

AU - Sarkar, Shubhashish

AU - Singh, Pomila

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Progastrin (PG) exerts proliferative and antiapoptotic effects on intestinal epithelial and colon cancer cells via Annexin II (ANX-II). In here, we show that ANX-II similarly mediates proliferative and antiapoptotic effects of PG on a pancreatic cancer cell line, AR42J. The role of several signaling molecules was examined in delineating the biological activity of PG. PG (0.1-1.0 nmol/L) caused a significant increase (2- to 5-fold) in the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt (Thr308), p38 mitogen-activated protein kinase (MAPK; Thr180/Tyr182), extracellular signal-regulated kinases (ERK; Thr202/Tyr 204), IκB kinase α/β (IKKα/β; Ser 176/180), IκBα (Ser32), and p65 nuclear factor-κB (NF-κB; Ser536). Inhibition of p44/42 ERKs (PD98059), p38 MAPK (SB203580), Akt, and PI3K (LY294002), individually or combined, partially reversed antiapoptotic effects of PG. The kinetics of phosphorylation of IKKα/β in response to PG matched the kinetics of phosphorylation and degradation of IκBβ and correlated with phosphorylation, nuclear translocation, and activation of p65 NF-κB. NF-κB essential modulator-binding domain peptide (an inhibitor of IKKα/β) effectively blocked the activity of p65 NF-κB in response to PG. Activation of p65 NF-κB, in response to PG, was 70% to 80% dependent on phosphorylation of MAPK/ERK and PI3K/Akt molecules. Down-regulation of p65 NF-κB by specific small interfering RNA resulted in the loss of antiapoptotic effects of PG on AR42J cells. These studies show for the first time that the canonical pathway of activation of p65 NF-κB mediates antiapoptotic effects of PG. Therefore, targeting PG and/or p65 NF-κB may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth.

AB - Progastrin (PG) exerts proliferative and antiapoptotic effects on intestinal epithelial and colon cancer cells via Annexin II (ANX-II). In here, we show that ANX-II similarly mediates proliferative and antiapoptotic effects of PG on a pancreatic cancer cell line, AR42J. The role of several signaling molecules was examined in delineating the biological activity of PG. PG (0.1-1.0 nmol/L) caused a significant increase (2- to 5-fold) in the phosphorylation of phosphatidylinositol 3-kinase (PI3K), Akt (Thr308), p38 mitogen-activated protein kinase (MAPK; Thr180/Tyr182), extracellular signal-regulated kinases (ERK; Thr202/Tyr 204), IκB kinase α/β (IKKα/β; Ser 176/180), IκBα (Ser32), and p65 nuclear factor-κB (NF-κB; Ser536). Inhibition of p44/42 ERKs (PD98059), p38 MAPK (SB203580), Akt, and PI3K (LY294002), individually or combined, partially reversed antiapoptotic effects of PG. The kinetics of phosphorylation of IKKα/β in response to PG matched the kinetics of phosphorylation and degradation of IκBβ and correlated with phosphorylation, nuclear translocation, and activation of p65 NF-κB. NF-κB essential modulator-binding domain peptide (an inhibitor of IKKα/β) effectively blocked the activity of p65 NF-κB in response to PG. Activation of p65 NF-κB, in response to PG, was 70% to 80% dependent on phosphorylation of MAPK/ERK and PI3K/Akt molecules. Down-regulation of p65 NF-κB by specific small interfering RNA resulted in the loss of antiapoptotic effects of PG on AR42J cells. These studies show for the first time that the canonical pathway of activation of p65 NF-κB mediates antiapoptotic effects of PG. Therefore, targeting PG and/or p65 NF-κB may be useful for treating cancers, which are dependent on autocrine or circulating PGs for their growth.

UR - http://www.scopus.com/inward/record.url?scp=34547621429&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547621429&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-07-1206

DO - 10.1158/0008-5472.CAN-07-1206

M3 - Article

C2 - 17671195

AN - SCOPUS:34547621429

VL - 67

SP - 7266

EP - 7274

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 15

ER -